|
ZBTB4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.880300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.242300E-02 |
| Normal-vs-Stage2 |
1.794340E-02 |
| Normal-vs-Stage3 |
1.046000E-02 |
| Normal-vs-Stage4 |
3.51700000000843E-06 |
| Stage1-vs-Stage2 |
4.286200E-01 |
| Stage1-vs-Stage3 |
1.780230E-01 |
| Stage1-vs-Stage4 |
2.127500E-02 |
| Stage2-vs-Stage3 |
7.317200E-01 |
| Stage2-vs-Stage4 |
7.428400E-02 |
| Stage3-vs-Stage4 |
2.333400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.183600E-03 |
| Normal-vs-AfricanAmerican |
3.325000E-03 |
| Normal-vs-Asian |
1.126370E-02 |
| Caucasian-vs-AfricanAmerican |
5.851600E-01 |
| Caucasian-vs-Asian |
3.683000E-01 |
| AfricanAmerican-vs-Asian |
4.044000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.849200E-04 |
| Normal-vs-Female |
1.109560E-01 |
| Male-vs-Female |
2.129600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.457980E-03 |
| Normal-vs-Extreme_Weight |
2.158500E-03 |
| Normal-vs-Obese |
1.535780E-01 |
| Normal-vs-Extreme_Obese |
1.807840E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.423000E-01 |
| Normal_Weight-vs-Obese |
5.882000E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.975600E-01 |
| Extreme_Weight-vs-Obese |
1.383980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.245600E-01 |
| Obese-vs-Extreme_Obese |
3.073600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.192000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.379640E-01 |
| Normal-vs-Age(61-80Yrs) |
9.62049999999604E-05 |
| Normal-vs-Age(81-100Yrs) |
1.971650E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.283000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.170400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.706000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.505600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.792000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.611770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.575190E-01 |
| Normal-VS-Type2 PRCC |
3.34840000171255E-08 |
| Normal-VS-KIRP CIMP |
1.436410E-02 |
| Normal-VS-Unclassified PRCC |
5.288000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.43840000044993E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.622000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.958600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.682000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.630100E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.638000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0332999999837E-06 |
| Normal-vs-N1 |
5.78039999999946E-05 |
| Normal-vs-N2 |
3.037500E-03 |
| N0-vs-N1 |
9.620800E-01 |
| N0-vs-N2 |
5.543800E-01 |
| N1-vs-N2 |
5.533200E-01 |
|
|
